You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
22 July 2026 -

West Pharmaceutical Services Inc (NYSE:WST), a manufacturer of containment and delivery solutions for injectable medicines, announced on Tuesday that its board of directors has declared a regular quarterly dividend of USD0.22 per share on the company's common stock.

This amount is unchanged from the previous quarterly dividend.

The dividend is payable on 5 August 2026 to shareholders of record as of 29 July 2026.

Login
Username:

Password:


Related Headlines

Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones

Labcorp declares quarterly dividend of USD0.72 per share

Aptamer Group launches Optimer-based Ebola diagnostic programme

SK bioscience to lead Gates Foundation-funded ROTOR project

Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases

Lilly declares Q3 2026 dividend

Abbott declares quarterly dividend of USD0.63 per share

Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda

INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100

Lilly declares Q2 2026 dividend

Collegium to acquire AZSTARYS from Corium Therapeutics

CVS Health announces quarterly dividend of USD0.665 per share

Convatec launches co-branded eakin freeseal ostomy seal in North America

UHS to acquire Talkspace for USD835m

Abbott announces quarterly dividend

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026